DIANNA ANDRES: Open Payments
NPI 1063172047 · YARDLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 113 payments from 23 companies in 2025. Trend: 2023 $1,270 · 2024 $1,591 · 2025 $1,907
Food & beverage: $1,907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $377 |
| Lilly USA, LLC | 11 | $196 |
| PFIZER INC. | 21 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $99 |
| Exact Sciences Corporation | 5 | $95 |
| Verona Pharma, Inc. | 3 | $79 |
| Lundbeck LLC | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
Products named: UBRELVY, CAPLYTA, QULIPTA, VRAYLAR, XIFAXAN, JARDIANCE, MOUNJARO, REXULTI.
Industry payments across PA — which companies pay providers there.
